綠茶萃取 Green Tea Extract
C 1 D 2
適應症與證據等級
法規與權威立場 (L4)
L4a · US FDA
立場:cautious
Oil-soluble green tea extract (green tea catechin palmitate) is considered Generally Recognized as Safe (GRAS) based on scientific procedures as an antioxidant in food
來源 ↗ L4b · EU EFSA
立場:against
L4c · UK NHS
立場:cautious
The COT concluded that there are no new data to suggest that EFSA's conclusion, that 800 mg/day EGCG was probably safe, is inappropriate. Although no new studies identified any effects of EGCG in humans at doses below 800 mg/day, the possibility cannot be excluded that a few individuals could still experience adverse effects below this dose due to an idiosyncratic reaction.
來源 ↗ L4e · WHO
立場:not_addressed
Tea is not classifiable as to its carcinogenicity to humans (Group 3). [IARC Monographs Vol. 51, 1991 — inadequate evidence of carcinogenicity in humans]
來源 ↗ 市場與行銷 (L10)
L10a · TW Market Channels
綠恩兒茶素(綠茶萃取錠)獲衛福部健康食品認證,編號為衛署健食字第A00179號
L10b · TW Legal Identity (TFDA)
臺灣針對經萃取出綠茶兒茶素EGCG製成的保健膠囊都有規範,必須符合每日上限300毫克的限制才可以販售
L10c · TW Community (PTT/Dcard/Mobile01)
論文有效,但喝茶沒感覺的也大有人在